Abstract
In Drosophila melanogaster, ageing is slowed when insulin-like signalling is reduced: life expectancy is extended by more than 50% when the insulin-like receptor (InR) or its receptor substrate (chico) are mutated, or when insulin-producing cells are ablated1,2,3. But we have yet to resolve when insulin affects ageing, or whether insulin signals regulate ageing directly or indirectly through secondary hormones. Caenorhabditis elegans lifespan is also extended when insulin signalling is inhibited in certain tissues, or when repressed in adult worms4,5, and this requires the forkhead transcription factor (FOXO) encoded by daf-16 (ref. 6). The D. melanogaster insulin-like receptor mediates phosphorylation of dFOXO, the equivalent of nematode daf-16 and mammalian FOXO3a7,8. We demonstrate here that dFOXO regulates D. melanogaster ageing when activated in the adult pericerebral fat body. We further show that this limited activation of dFOXO reduces expression of the Drosophila insulin-like peptide dilp-2 synthesized in neurons, and represses endogenous insulin-dependent signalling in peripheral fat body. These findings suggest that autonomous and non-autonomous roles of insulin signalling combine to control ageing.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The remoulding of dietary effects on the fecundity / longevity trade-off in a social insect
BMC Genomics Open Access 05 May 2023
-
The Role of microRNA-23a-3p in the Progression of Human Aging Process by Targeting FOXO3a
Molecular Biotechnology Open Access 23 April 2023
-
Use of Animal Models for Investigating Cardioprotective Roles of SGLT2 Inhibitors
Journal of Cardiovascular Translational Research Open Access 13 April 2023
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout




References
Clancy, D. J. et al. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292, 104–106 (2001)
Tu, M.-P., Epstein, D. & Tatar, M. The demography of slow aging in male and female Drosophila mutant for the insulin-receptor substrate homolog chico. Aging Cell 1, 75–80 (2002)
Tatar, M. et al. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292, 107–110 (2001)
Dillin, A., Crawford, D. K. & Kenyon, C. Timing requirements for insulin/IGF-1 signaling in C. elegans. Science 298, 830–834 (2002)
Libina, N., Berman, J. R. & Kenyon, C. Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan. Cell 115, 489–502 (2003)
Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464 (1993)
Puig, O., Marr, M. T., Ruhf, M. L. & Tjian, R. Control of cell number by Drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway. Genes Dev. 17, 2006–2020 (2003)
Junger, M. A. et al. The Drosophila Forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J. Biol. [online] 2, Article 20; 〈http://jbiol.com/content/2/3/20〉 (2003).
Roman, G., Endo, K., Zong, L. & Davis, R. L. P{Switch}, a system for spatial and temporal control of gene expression in Drosophila melanogaster. Proc. Natl Acad. Sci. USA 98, 12602–12607 (2001)
Osterwalder, T., Yoon, K. S., White, B. H. & Keshishian, H. A conditional tissue-specific transgene expression system using inducible GAL4. Proc. Natl Acad. Sci. USA 98, 12596–12601 (2001)
Dobens, L. L. et al. The Drosophila bunched gene is a homologue of the growth factor stimulated mammalian TSC-22 sequence and is required during oogenesis. Mech. Dev. 65, 197–208 (1997)
Tatar, M., Bartke, A. & Antebi, A. The endocrine regulation of aging by insulin-like signals. Science 299, 1346–1351 (2003)
Ashrafi, K. et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421, 268–272 (2003)
Garofalo, R. S. Genetic analysis of insulin signaling in Drosophila. Trends Endocrinol. Metab. 13, 156–162 (2002)
Rulifson, E. J., Kim, S. K. & Nusse, R. Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science 296, 1118–1120 (2002)
Cao, C. & Brown, M. R. Localization of an insulin-like peptide in brains of two flies. Cell Tissue Res. 304, 317–321 (2001)
Brogiolo, W. et al. An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr. Biol. 11, 213–221 (2001)
Wolkow, C. A., Kimura, K. D., Lee, M.-S. & Ruvkun, G. Regulation of C. elegans life-span by insulin-like signaling in the nervous system. Science 290, 147–150 (2000)
Blüher, M., Kahn, B. B. & Kahn, R. C. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299, 572–574 (2003)
Blüher, M. et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 3, 25–38 (2002)
Simon, A. F., Shih, C., Mack, A. & Benzer, S. Steroid control of longevity in Drosophila melanogaster. Science 299, 1407–1410 (2003)
Gerisch, B., Weitzel, C., Kober-Eisermann, C., Rottiers, V. & Antebi, A. A hormonal signaling pathway influencing C. elegans metabolism, reproductive development, and life span. Dev. Cell 1, 841–851 (2001)
Jia, K., Albert, P. S. & Riddle, D. L. DAF-9, a cytochrome P450 regulating C. elegans larval development and adult longevity. Development 129, 221–231 (2002)
Murphy, C. T. et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277–284 (2003)
Saucedo, L. J. et al. Rheb promotes cell growth as a component of the insulin/TOR signaling network. Nature Cell Biol. 5, 566–571 (2003)
Vellai, T. et al. Influence of TOR kinase on lifespan in C. elegans. Nature 426, 620 (2003)
Acknowledgements
We thank F. Lemieux, A. Bentle, M. Duon and M. Zerofsky for technical support, and A. Brunet, J. Wasserman, B. Edgar, G. Roman, O. Puig and T. Osterwalder for materials. This work was supported by the National Institute of Health (Institute of Aging), the American Federation of Aging Research, the Ellison Medical Foundation and a collaborative research grant from Pfizer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing financial interests.
Supplementary information
Supplementary Figure S1
Expression of exogenous dFOXO in the eye disc reduces growth. We verify that our transformed strains produce eye growth phenotypes similar to those reported by previously published strains with UAS-FOXO. We test several independent inserts of both the wildtype dFOXO and the phosphorylation site mutant dFOXO-TM. We also demonstrate that our mifepristone feeding protocol induces the expected expression patterns with ELAV-{PSwitch}.
Supplementary Figure S2
These trials show that feeding mifepristone in yeast paste has no effect on survival or males or females. Data are presented to show that expression of dFOXO-TM in the head fat body, which increases longevity, does not alter gross fecundity.
Supplementary Figure S3
This series of cryosection images show that induction of exogenous dFOXO-TM in the abdominal fat body is effective but does not cause a change in the endogenous dFOXO of the head fat body.
Supplementary Figure S4
Abundance of dilp mRNA from head measured by microarray. Insulin producing cells of adults are in the brain; dFOXO-TM was induced in the pericerebral fat body and produced a small but significant decrease in dilp2 from these neurons. These array data are refined and verified by real-time PCR analysis in the full text.
Supplementary Figure S5
The driver S32 is restricted to expression in the adult head. Using primers for sequence specific to the exogenous dFOXO-TM, message is detected in cDNA from head tissue and not from abdominal tissue.
Supplementary Table S1
When expressed through larval stages with broadly active drivers, dFOXO wildtype and phosphorylation mutant are lethal.
Supplementary Table S2
Summary of life table statistics for demographic trials with fat body and CNS-related mifepristone activated drivers directed at dFOXO, dFOXO-TM and PTEN. Data are given for male and females, and for the wildtype control trial plotted in Supplementary Figure 2.
Rights and permissions
About this article
Cite this article
Hwangbo, D., Gersham, B., Tu, MP. et al. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature 429, 562–566 (2004). https://doi.org/10.1038/nature02549
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nature02549
This article is cited by
-
The remoulding of dietary effects on the fecundity / longevity trade-off in a social insect
BMC Genomics (2023)
-
Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction?
Molecular Psychiatry (2023)
-
Use of Animal Models for Investigating Cardioprotective Roles of SGLT2 Inhibitors
Journal of Cardiovascular Translational Research (2023)
-
The Role of microRNA-23a-3p in the Progression of Human Aging Process by Targeting FOXO3a
Molecular Biotechnology (2023)
-
Transcriptional memory of dFOXO activation in youth curtails later-life mortality through chromatin remodeling and Xbp1
Nature Aging (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.